Uniter

Uniter Biopharma is a specialized biopharmaceutical company focused on the development of high-end inhalation drugs for respiratory diseases such as asthma and Chronic Obstructive Pulmonary Disease (COPD). Based in Beijing, the company leverages its proprietary technology platforms for Dry Powder Inhalers (DPI) and Soft Mist Inhalers (SMI) to develop both complex generics and innovative therapeutic combinations. Uniter's pipeline includes several late-stage programs designed to provide high-quality, cost-effective alternatives to established global respiratory brands like Advair and Spiriva. The company is positioned as a leader in the Chinese inhalation market, addressing the significant unmet need for accessible respiratory care through advanced device-drug combination products.